Stephens Adjusts UnitedHealth Group Price Target to $645 From $675
Bernstein Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $697
Morgan Stanley Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $610
Bernstein Issues a Buy Rating on UnitedHealth (UNH)
UnitedHealth Buy Rating: Strong Growth Prospects and Value Opportunity Amid Industry Challenges
HSBC Upgrades UnitedHealth(UNH.US) to Buy Rating, Maintains Target Price $595
HSBC Upgrades UnitedHealth to Buy From Hold, Price Target Is $595
Truist Financial Maintains UnitedHealth(UNH.US) With Buy Rating, Announces Target Price $610
Truist Securities Maintains Buy on UnitedHealth Group, Lowers Price Target to $610
UnitedHealth Group Analyst Ratings
Piper Sandler Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $600
Piper Sandler Maintains Overweight on UnitedHealth Group, Lowers Price Target to $600
UnitedHealth Group Analyst Ratings
Raymond James Maintains UnitedHealth(UNH.US) With Buy Rating
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $655
Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS) and UnitedHealth (UNH)
Bernstein Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $658
Morgan Stanley Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $610
Morgan Stanley Sticks to Its Buy Rating for UnitedHealth (UNH)
Bernstein Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $658